The pandemic continues to accelerate consumer pressure to bring legal cannabis-derived products, including cannabidiol (CBD)-containing foods, beverages, supplements, and pet treats, to market. Judging from current market activity, if and when the U.S. Food and Drug Administra-tion (FDA) issues CBD regulations, it will have been well worth the wait—for marketers of edibles in particular.
CBD is a non-psychoactive cannabinoid derived from the herbal flowering plant family, Cannabis sativa, which i…